Abstract
Despite prompt antibiotic treatment of microbial infections and aggressive intensive care of the critically ill, progression to the septic shock syndrome remains common and mortality still exceeds 50% [1, 2]. This situation has promoted the distinction between infections as microbiological phenomena, and septic shock as a complex series of deleterious host responses to such microbial invasion [1, 3]. Two factors have been important in shaping the current widely-held conception that these host-derived inflammatory responses are stereotypically activated in infected subjects regardless of the type of pathogen. The first may be termed an argument based on the clinical equivalency of pathogen-specific sepsis. Physiologic and metabolic derangements during severe infection by taxonomically diverse organisms (e.g. Gram-negative bacteria, Gram-positive bacteria, pathogenic fungi, rickettsiae, and viruses) often are clinically indistinguishable [3–5]. Thus, the inflammatory events responsible for these clinical derangements are thought to be similar. Initially manifested by the systemic inflammatory response syndrome (SIRS), these events lead to circulatory instability with respiratory distress according to the extent of infection and/or the intensity of the host response, culminating in multiple organ failure (MOF) [1,2].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Livingston DH, Mosenthal AC, Deitch EA (1995) Sepsis and multiple organ dysfunction syndrome: A clinical-mechanistic overview. New Horiz 3: 257–266
Arend WP (1995) Inhibiting the effects of cytokines in human diseases. Adv Intern Med 40: 365–394
Bamberger DM, Gurley MB (1994) Microbial etiology and clinical characteristics of distributive shock. Clin Infect Dis 18: 726–730
Wakabayashi G, Gelfand JA, Jung WK, et al (1991) Staphylococcus epidermidis induces complement activation, tumor necrosis factor, and interleukin-1, a shock-like state, and tissue injury in rabbits without endotoxemia. J Clin Invest 87: 1925–1935
Byerley LO, Alcock NW, Starnes HF (1992) Sepsis-induced cascade of cytokine mRNA expression: Correlation with metabolic changes. Am J Physiol 261: E728 - E735
Ziegler EJ, Fisher CJ, Sprung CL, et al (1991) Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. N Engl J Med 324: 429–436
Rogy MA, Moldawer LL, Oldenburg HSA, et al (1994) Anti-endotoxin therapy in primate bacteremia with HA-1A and BPI. Ann Surg 220: 77–85
Goldie AS, Fearon KCH, Ross JA, et al (1995) Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. JAMA 274: 172–177
Marra MN, Thornton MB, Snable JL, Wilde CG, Scott RW (1994) Endotoxin binding and neutralizing properties of recombinant bactericidal/permeability-increasing protein and monoclonal antibodies HA-1A and E5. Crit Care Med 22: 559–565
Fisher CJ, Marra MN, Palardy JE, Marchbanks CR, Scott RW, Opal SM (1994) Human neutrophil bactericidal/permeability-increasing protein reduces mortality rate from endotoxin challenge: A placebo-controlled study. Crit Care Med 22: 553–558
Lechner AJ, Lamprech KE, Johanns CA, Matuschak GM (1995) The recombinant 23-kDa N-terminal fragment of bactericidal/permeability-increasing protein (rBPI23) decreases E. coli-induced mortality and organ injury during immunosuppression-related neutropenia. Shock 4: 298–306
Novogrodsky A, Vanichkin A, Patya M, et al (1995) Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. Science 264: 1319–1322
Lang F, Robert JM, Boucrot P, Welin L, Petit JY (1995) New anti-inflammatory compounds that inhibit tumor necrosis factor production: Probable interaction with protein kinase C activation. J Pharm Exp Ther 275: 171–176
Lechner AJ, Rouben LR, Potthoff LH, Tredway TL, Matuschak GM (1993) Effects of pentoxifylline on tumor necrosis factor production and survival during lethal E. coli sepsis vs disseminated candidiasis with fungal septic shock. Circ Shock 39: 306–315
Dhainaut JFA, Vincent JL, Richard C, et al (1995) CDP571, a humanized antibody to tumor necrosis factor-a: Safety, pharmacokinetics, immune response, and influence of the antibody on cytokine concentrations in patients with septic shock. Grit Care Med 23: 1461–1469
Fisher CJ, Agosti JM, Opal SM, et al (1996) Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. N Engl J Med 334: 1697–1702
Lechner AJ, Johanns CA, Matuschak GM (1997) A recombinant TNF-a p80 receptor:Fc fusion protein decreases circulating bioactive TNF-a but not lung injury or mortality during immunosuppression-related Gram-negative bacteremia. J Crit Care (In press)
Fisher CJ, Slotman GJ, Opal SM, et al (1994) Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: A randomized, open-label, placebo-controlled multicenter trial. Grit Care Med 22: 12–21
Vincent JL, Bihari DJ, Suter PM, et al (1995) The prevalence of nosocomial infection in intensive care units in Europe. JAMA 274: 639–644
Jarvis WR (1995) Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 20: 1526–1530
Fisher-Hoch SP, Hutwagner L (1995) Opportunistic candidiasis: An epidemic of the 1980s. Clin Infect Dis 21: 897–904
Eubanks PJ, de Virgilio C, Klein S, et al (1995) Candida sepsis in surgical patients. Am J Surg 166: 617–619
Cutler JE (1991) Putative virulence factors of C. albicans. Ann Rev Microbiol 45: 187–218
Calderone RA, Braun PC (1991) Adherence and receptor relationships of Candida albicans. Microbiol Rev 55: 1–20
Blasi E, Pitzurra L, Chimienti AR, et al (1995) Differential susceptibility of yeast and hyphal forms of Candida albicans to proteolytic activity of macrophages. Infect Immun 63: 12531257
Matuschak GM, Lechner AJ (1997) The yeast-hyphal transition following hematogenous candidiasis induces shock and organ injury independent of circulating tumor necrosis factor-a. Crit Care Med (In press)
Pendrak ML, Klotz SA (1995) Adherence of Candida albicans to host cells. FEMS Microbiol Lett 129: 103–114
Casanova M, Lopez-Ribot JL, Monteagudo C, et al (1992) Identification of a 58-kD cell surface fibrinogen-binding mannoprotein from Candida albicans. Infect Immun 60: 4221–4229
Matuschak GM, Lechner AJ (1992) Hepatic regulation of systemic host defense and its derangement in multiple systems organ dysfunction and failure. In: Matuschak GM (ed) Multiple Systems Organ Failure, 1st edn. Marcel-Dekker, New York, pp 1–38
Lechner AJ, Tredway TL, Brink DS, Klein CA, Matuschak GM (1992) Differential systemic and intrapulmonary TNF-a production in Candida sepsis during immunosuppression. Am J Physiol 263: L526 - L535
Matuschak GM, Klein CA, Tredway TL, Schilly DR, Lechner AJ (1993) TNF-a and cyclooxygenase metabolites do not modulate C. albicans septic shock with disseminated candidiasis. J Appl Physiol 74: 2432–2442
Peters BG,Adkins DR, Harrison BR, et al (1996) Antifungal effects of yeast-derived rhu-GM-CSF in patients receiving high-dose chemotherapy with or without autologous stem cell transplantation: A retrospective analysis. Bone Mar Transpl 18: 93–102
Jensen J, Warner T, Balish E (1993) Resistance of SLID mice to Candida albicans administered intravenously or colonizing the gut: Role of polymorphonuclear leukocytes and macrophages. J Infect Dis 167: 912–919
Jensen J, Warner T, Balish E (1994) The role of phagocytic cells in resistance to disseminated candidiasis in granulocytopenic mice. J Infect Dis 170: 900–905
Altamura M, Geronimo MG, Lofrumento DD, et al (1995) Immune effector mechanisms in the control of Candida albicans infection: A review. Biomed Lett 51: 197–211
Ashman RB, Papadimitriou JM (1995) Production and function of cytokines in natural and acquired immunity to Candida albicans infection. Microbiol Rev 59: 646–672
Ausiello CM, Urbani F, Gessani S, et al (1994) Cytokine gene expression in human peripheral blood mononuclear cells stimulated by mannoprotein constituents from Candida albicans. Infect Immun 61: 4105–4111
Murthy ARK, Lehrer RI, Harwig SSL, Miyasaki KT (1993) In vitro candidastatic properties of the human neutrophil calprotectin complex. J Immunol 151: 6291–6301
Palma C, Cassone A, Serbousek D, Pearson CA, Djeu JY (1992) Lactoferrin release and IL-1, IL-6, and TNF production by human polymorphonuclear cells stimulated by various lipopoly-saccharides: Relationship to growth inhibition of Candida albicans. Infect Immun 60: 4604–4611
Cole GT, Saha K, Seshan KR, et al (1992) Retrovirus-induced immunodeficiency in mice exacerbates gastrointestinal candidiasis. Infect Immun 60: 4168–4178
van’t Wout JW, Poell R, van Furth R (1992) The role of BCG/PPD-activated macrophages in resistance against systemic candidiasis in mice. Scand J Immunol 36: 713–719
Blasi E, Puliti M, Pitzurra L, Bartoli A, Bistoni F (1994) Heterogeneous secretory response of phagocytes from different anatomical districts to the dimorphic fungus Candida albicans. Cell Immunol 153: 239–247
Yamamoto Y, Specter S, Friedman H (1993) Lipopolysaccharide restores anti-Candida albicans growth inhibition activity of polymorphonuclear neutrophils from retrovirus-immunosuppressed mice. Infect Immun 61: 2216–2219
Melissen PMB, van Vianen W, Bakker-Woudenberg IAJM (1994) Treatment of Klebsiella pneumoniae septicemia in normal and leukopenic mice by liposome-encapsulated muramyl tripeptide phosphatidylethanolamide. Antimicrob Agents Chemother 38: 147–150
Blasi E, Pitzurra L, Bartoli A, Puliti M, Bistoni F (1994) TNF as an autocrine and paracrine signal controlling the macrophage secretory response to C. albicans. Infect Immun 62: 1199–1206
Roilides E, Uhlig K, Venzon D, Pizzo PA, Walsh TJ (1992) Neutrophil oxidative burst in response to blastoconidia and pseudohyphae of Candida albicans: Augmentation by granulocyte colony-stimulating factor and interferon-y. J Infect Dis 166: 668–673
Romani L, Mencacci A, Grohmann U, et al (1992) Neutralizing antibody to IL-4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis. J Exp Med 176: 19–25
Cenci E, Romani L, Mencacci A, et al (1993) Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur J Immunol 23: 1034–1038
Louie A, Baltch AL, Smith RP, et al (1994) TNF-a has a protective role in a murine model of systemic candidiasis. Infect Immun 62: 2761–2772
Perfect JR, Pickard WW, Hunt DL, Palmer B, Schell WA (1991) The use of amphotericin B in nosocomial fungal infection. Rev Infect Dis 13: 474–479
Hathorn JW (1993) Critical appraisal of antimicrobials for prevention of infections in immunocompromised hosts. Hematol Oncol Clin N Am 7: 1051–1099
Goodman JL, Winston DJ, Greenfield RA (1992) A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 326: 845–851
Kullberg BJ, van’t Wout JW, Poell RJM, van Furth R (1992) Combined effect of fluconazole and recombinant human interleukin-1 on systemic candidiasis in neutropenic mice. Antimicrob Agents Chemother 36: 1225–1229
Lechner AJ, Lamprech KE, Potthoff LH, Tredway TL, Matuschak GM (1994) Recombinant GMCSF reduces lung injury and mortality during neutropenic Candida sepsis. Am J Physiol 266: L561 - L568
Lechner AJ, Haines WR, Lamprech KE, Johanns CA, Matuschak GM (1996) Endotoxin pretreatment improves survival during immunosuppression-related candidemia. Shock 5S: 33–34 (Abst)
Lechner AJ, Lamprech KE, Johanns CA, Matuschak GM (1995) Pulmonary TNF-a responses following fungal or gram-negative bacterial challenge. Am J Respir Crit Care Med 151: A322 (Abst)
Olynyk JK, Matuschak GM, Lechner AJ, et al (1994) Differential production of TNF-a by Kupffer cells after phagocytoses of E. coli and C. albicans. Am J Physiol 267: G213 - G219
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Lechner, A.J., Matuschak, G.M. (1997). Cytokine-Mediated Enhancement of Host Defense. In: Vincent, JL. (eds) Yearbook of Intensive Care and Emergency Medicine 1997. Yearbook of Intensive Care and Emergency Medicine, vol 1997. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-13450-4_11
Download citation
DOI: https://doi.org/10.1007/978-3-662-13450-4_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-13452-8
Online ISBN: 978-3-662-13450-4
eBook Packages: Springer Book Archive